— Know what they know.
Not Investment Advice
Also trades as: 0UNL.L (LSE) · $vol 0M

NKTR NASDAQ

Nektar Therapeutics
1W: +2.2% 1M: -34.4% 3M: -47.1% YTD: -13.8% 1Y: -41.1% 3Y: +362.4% 5Y: -84.7%
$37.97
+0.52 (+1.39%)
After Hours: $38.12 (+0.16, +0.41%)
Weekly Expected Move ±13.7%
$27 $32 $37 $42 $47
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $1.1B mcap · 29M float · 3.87% daily turnover · Short 50% of daily vol
Credit Risk of going bust: higher than 66% of companies Debt: 11.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.56 (down 99%), Nektar Therapeutics would be worth roughly what it owes.
Total debt $135.9M against a stock market value of $1.07B.
Distance to default 3.71 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $51.4M (short-term plus half of long-term), stock volatility 79.9%; Altman Z'' -3.33. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Oct Typical
☀️
Sunny
+14.4% YTD avg
Midterm Year
⛈️
Stormy
-10.7% YTD avg
2026 Now
⛈️
Stormy
Below typical
20yr Avg YTD
+14.4%
Day 206 of 252
Midterm Year YTD
-10.7%
Presidential cycle avg
2026 YTD
-12.6%
Below 20yr avg
Typical Vol
65%
Annualized
Monthly Weather Forecast
Jan
20yr
💨
+4.6%
Midterm
☀️
+16.7%
45% win 65% vol
Feb
20yr
💨
+4.4%
Midterm
☀️
+23.2%
55% win 87% vol
Mar
20yr
💨
+6.8%
Midterm
☀️
+20.4%
50% win 86% vol
Apr
20yr
🌫️
+6.6%
Midterm
☀️
+12.5%
40% win 71% vol
May
20yr
⛈️
+1.5%
Midterm
⛅
+3.4%
20% win 61% vol
Jun
20yr
💨
+3.9%
Midterm
⛈️
-8.6%
45% win 140% vol
Jul
20yr
💨
+4.5%
Midterm
⛈️
-10.1%
55% win 54% vol
Aug
20yr
💨
+6.0%
Midterm
⛅
+1.0%
50% win 94% vol
Sep
20yr
💨
+19.1%
Midterm
⛈️
-5.8%
45% win 62% vol
Oct
20yr
⛈️
+13.3%
Midterm
⛈️
-11.1%
33% win 65% vol
Now: -37.3%
Nov
20yr
💨
+22.0%
Midterm
⛈️
-9.0%
60% win 73% vol
Dec
20yr
🌫️
-0.0%
Midterm
⛈️
-10.3%
60% win 56% vol
Seasonality (20yr)
Updated: 2026-10-27
YTD: -12.6%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms